Hear insights from Stefan Zeuzem, MD, on exciting new data on viral hepatitis reported at the virtual EASL 2021, including new findings on treatment of HDV, treatment of HBV and HCV in children, linking patients to care, and new molecules being investigated for HBV cure.
Hear a rapid update of the top HBV, HCV, and HDV studies from the Virtual 2021 International Liver Congress, 2021.
Hear a rapid update of the top HBV, HCV, and HDV studies from the Virtual 2021 International Liver Congress, 2021.
In this downloadable slideset, CCO’s expert faculty members summarize key viral hepatitis studies from this important conference, including new data on treatment of HDV, treatment of HBV and HCV in children, linking patients to care, and new molecules being investigated for HBV cure.
Now that the horizon is getting closer, our job now is to identify our HDV-infected patients and prepare them for treatment.
My thoughts on which HBV cure strategies might be fruitful.
*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.